Jiangsu Nanfang Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of transdermal products, medical a...
The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down
NANFANG MEDICAL: Net profit loss of 12.9677 million yuan in the first half of 2025
NANFANG MEDICAL: It is expected that the net profit attributable to the owners of the parent company in the first half of the year will be a loss of 12 million to 16 million yuan, turning from profit to loss year-on-year
Medical device concept stocks continue to rise, Hob Biotech hits the 20% limit up in the afternoon
The medical device sector saw a short-term surge, with NANFANG MEDICAL hitting the daily limit